EIF4BP9

Across TCGA pan-cancer cohorts, EIF4BP9 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated EIF4BP9 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher EIF4BP9 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated EIF4BP9 expression acts as an unfavorable survival marker, although some lineages such as COAD and UCS show a favorable association.

COAD, OV, and UCS are the cancer types where EIF4BP9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Tertile	All	0.815	0.593	.001	57	view →
OV	OS	Median	All	0.265	0.366	<.001	54	view →
UCS	OS	Quartile	II,III,IV	0.614	0.258	.020	40	view →
KIRC	DFS	Quartile	II,III,IV	0.940	0.674	.012	36	view →
DLBC	OS	Quartile	II,III,IV	0.640	1.000	.022	26	view →
KIRP	DFS	Tertile	III,IV	0.222	0.612	.010	24	view →
THYM	DFS	Median	II,III,IV	1.000	0.745	.006	20	view →
SKCM	OS	Tertile	All	0.849	0.766	.008	15	view →
BLCA	DFS	Tertile	IV	0.349	0.163	.022	10	view →
THCA	DFS	Median	III,IV	0.890	0.762	.020	10	view →
KICH	DFS	Tertile	IV	0.269	0.784	.045	9	view →
PAAD	DFS	Median	III,IV	0.357	0.908	.038	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

EIF4BP9–COAD (DFS)

Open the COAD breakdown →